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Abstract This paper presents a novel class of systems assist-
ing diagnosis and personalised assessment of diseases in
healthcare. The targeted systems are end-to-end deep neu-
ral architectures that are designed (trained and tested) and
subsequently used as whole systems, accepting raw input
data and producing the desired outputs. Such architectures
are state-of-the-art in image analysis and computer vision,
speech recognition and language processing. Their appli-
cation in healthcare for prediction and diagnosis purposes
can produce high accuracy results and can be combined
withmedical knowledge to improve effectiveness, adaptation
and transparency of decision making. The paper focuses on
neurodegenerative diseases, particularly Parkinson’s, as the
development model, by creating a new database and using it
for training, evaluating and validating the proposed systems.
Experimental results are presented which illustrate the abil-
ity of the systems to detect and predict Parkinson’s based on
medical imaging information.
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Introduction
Current biomedical signal analysis, including medical imag-
ing, is based on signal processing for feature extraction,
segmentation, quantitative and qualitative analysis. Recent
advances in Machine Learning and Deep Neural Networks
(DNNs) have boosted state-of-the-art performance in all
related signal processing tasks. DNNs are the state-of-the-
art in machine learning and big data analytics, being used in
a large number of applications, ranging from defence and
surveillance to human computer interaction and question
answering systems [12,21,22]. DNNs can also be applied
as end-to-end-architectures which are composed of different
network types and are trained to analyse signals, images, text
and other inputs [12,19]. However, they lack on-line adap-
tation capability and transparency in decision making. This
makes their use difficult in fields such as healthcare, where
personalisation and trust are key issues.
The current paper aims at advancing the state-of-the-art,
by developing and using DNNs able to perform effective
analysis of complex data for healthcare, with focus on neu-
rodegenerative diseases, in particular Parkinson’s [3,11]. For
Parkinson’s disease (PD), we have the required medical sup-
port and expertise and a new public dataset, which enables
us to design an end-to-end neural architecture and platform
that can be adaptable to patient-specific data. We describe
a novel DNN system evaluated on a rich public Parkinson’s
dataset, which can serve as a model for many other related
fields.
Whilst Parkinson’s will provide the test-bed for the pro-
posed end-to-end deep neural system, this system will
provide an extensible handle for other neurodegenerative dis-
eases. This aligns directly with the Pathway Analysis across
Neurodegenerative Diseases described in [16], as ‘there
is clinical, genetic and biochemical evidence that similar
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molecular pathways are met in different neurodegenerative
diseases:Alzheimer’s and dementias, Parkinson’s and related
disorders, Huntington’s, motor neuron, prion, spinocerebel-
lar ataxia and spinal muscular atrophy’.
The target of this paper was to design and imple-
ment end-to-end deep neural architectures that can assist
doctors and clinicians in providing improved and more
accurate predictions and assessments, while overcoming
existing limitations. Focusing on a specific healthcare prob-
lem, we design DNN systems integrating imaging, demo-
graphic/epidemiological and clinical data, to support doctors
in patient-specific prediction and assessment. To achieve this
goal, we present a novel approach, developing a combined
supervised and unsupervised learning methodology. First,
data-driven supervised training of deep neural networks is
performed and, then, clustering of the derived network struc-
tures is applied to improve the derived results and allow
adaptation and handling of new subject cases.
Section “Generation of the Parkinson’s database” presents
the new Parkinson’s database, that we have been developing,
providing the necessary datasets for training and testing the
developed deep neural network systems. Section “Design of
deep neural architectures for healthcare” describes the design
of DNN architectures for prediction and diagnosis in health-
care applications. The proposed deep neural systems are
based on deep Convolutional (CNN) and Recurrent Neural
Networks (RNN), which prove to be able to process all types
of available data. A novel methodology for network adapta-
tion when facing new subjects, for personalised assessment,
as well as for providing transparency to the network’s per-
formance, is presented in Section “A novel method for deep
neural network adaptation and transparency”. An experimen-
tal study, illustrating the performance of the generated deep
neural architectures, is provided in Section “Experimental
study”. Conclusions and further planned work are given in
Section “Conclusions and further work” of the paper.
Generation of the Parkinson’s database
We have been creating a novel public dataset, currently
composed of 55 patients with Parkinson’s and 23 sub-
jects with Parkinson-related syndromes, including subjects’
MRI, DaT Scans and clinical data. Our target is that the
database soon includes 100 patients’ and 40 non-patients’
data. The database is becoming publicly available as Parkin-
son Dataset–v1 [27].
MRI data The rapid evolution of non-invasive medical imag-
ing techniques, over the past decades, has opened new
possibilities for the analysis of the brain. The basic imag-
ing technique is Magnetic Resonance Imaging (MRI) which
can yield from hundreds to even thousands of images per
scan. The assessment of this extremely large set of images
per patient can be complicated and time-consuming for doc-
tors. In Parkinson’s Disease, the MRI can show the extent to
which the different structures of the brain have been degen-
erated. Figure 1 shows an example of an MRI. Our main
interest regarding Parkinson’s is the lentiform nucleus (green
line in Fig. 2) and the capita of the caudate nucleus (red line
in Fig. 2). Since we focus on volume estimation, we pro-
cess the image sequences in batches, each composed of 3–4
consecutive frames.
DaT scan The second brain imaging technique included in
the database is Dopamine Transporters (DaT) Scan. This
examination is a form of Single-Photon Emission Computer
Tomography (SPECT)with Ioflupane Iodide-123 as it is con-
trast agent. In this examination, we can detect the extent of
dopaminergic innervations to the Striatum from the Substan-
Fig. 1 A frame of an axial T1 sequence from a brain MRI (right). Location of the previous slice is placed with regard to a sagittal view of the
brain (left)
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Fig. 2 An image from an axial T1 sequence. The lentiform nucleus is
depicted with a green line, while the capita of the caudate nucleus with
a red line
tiaNigra.A series of images is produced in thisway, as shown
in Fig. 3.
The doctor selects the most representative ones (the 8th in
the sequence of Fig. 3), andmarks the areas corresponding to
the head of the caudate nucleus. An automated system then
compares these areaswith a neutral one (e.g., the cerebellum)
andproduces the ratios shownat the bottomofFig. 4.Diagno-
sis is based on comparison of these ratios with normal ones.
Clinical data These define the patient’s clinical status. We
focused on the following scales: UPDRS, the patient’s stage,
UDysRS, PDQ-39, FOG, MMSE and two, timed tests [4].
The Unified Parkinson’s Disease Rating Scale (UPDRS)
[9] is a metric that examines the patient’s whole clinical per-
formance in 4 parts: motor/non-motor experiences of daily
living, motor examination and complications. These contain
13, 13, 18 and 6 elements, respectively, with each ranging
from 0 to 4 for a max score of 234.
The patient’s stage [14] represents the evolution of the
disease and ranges from asymptomatic (0) to bedridden (5).
The Unified Dyskinesia Rating Scale (UDysRS) [10] was
created for evaluating the involuntary movements associated
with PD; it has two parts measuring the dyskinesia and dys-
tonia appearing “on” and “off” phases, respectively. The first
part has 11 while the second 15 elements, all ranging from 0
(asymptomatic) to 4 (severe symptoms), for a total of 150.
The Parkinson’s Disease Questionnaire consists of 39
questions assessing patient’s functionality and quality of life
(PDQ-39) [17]. It can be separated into 8 different categories,
while each question represents the frequency of a specific
incident, ranging from0 (never occurring) to 5 (always occur-
ring), for a total of 156.
The “Freezing of Gait” (FOG) [8] is one of the most char-
acteristic PD symptoms. The quantification of this symptom
is achieved through the homonymous questionnaire which
contains 16 elements for a max rating of 24.
The Mini Mental State Examination (MMSE) [24] is an
11-question questionnaire meant to measure the cognitive
impairment associated with PD, with a max rating of 30.
Each of MRI and DaT Scan sets includes sequences/
multiple scans. For training, we combine annotated data from
both types to create thousands of input data, sufficient to train
the proposed systems.
Fig. 3 A sequence of frames
from a DaT scan
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Fig. 4 DaT scan with expert selection (left). Same image without the markings (right). Ratios, representing the dopamine deficiency, that are used
for the diagnosis (bottom)
Design of deep neural architectures for healthcare
Our main goal is to design deep neural architectures and
to evaluate their ability to extract correlations in the avail-
able datasets, providing a novel platform for assisting doctors
in detecting and assessing disease states. Validation is done
using the above-described Parkinson’s dataset. We also tar-
get at endowing our system with adaptation capabilities and
to test and validate it when handling new patient cases.
The technologies which we use and extend, in order to
develop the novel end-to-end deep neural architecture for
diagnosis and prediction are:
Deep convolutional neural networks Deep CNNs are archi-
tectures that try to exploit the spatial structure of input
information [12]. They have been used with great success in
various applications, including image analysis, vision, object
and emotion recognition. Themost successful CNNwas used
for classifying millions of images in 1000 classes [21].
Transfer learningTransfer learning [22] is themain approach
to avoid learning failure due to overfitting, when training
complex CNNswith small amounts of (image) data. In trans-
fer learning, we use networks previously trained with large
image datasets (even of generic objects) and fine-tune the
whole, or parts of them, using the small training datasets.
Recurrent neural networks RNNs are very powerful for pro-
cessing sequential data [18]. A very successful model, the
Long Short-Term Memory (LSTM) [25], uses hidden units
with gates that explicitly control data flow in terms of both
hidden states and inputs. Bidirectional (B-LSTM)models are
obtained by combining forward and backward processing of
input data. Gated Recurrent Units (GRUs) [2,12] can be used
in place of theBLSTMones; they have fewer parameters than
LSTMs, since they do not include an output gate. Based on
our tests with Parkinson’s data, GRUs have produced bet-
ter performances and are used in the experiments of Section
“Experimental study”.
Wepropose an end-to-end deep neural architecture includ-
ing both CNN and RNN components. CNNs derive rich
internal representations from input data; B-LSTM/GRU
RNNs correlate/analyse time evolution of the inputs, pro-
viding the final predictions. The CNN system we consider
follows the basic structure of the so called Deep Residual
Net (ResNet), which contains 50 layers [13]. This network
has won the first places on the tasks of ImageNet detection,
ImageNet localization, COCO (object) detection and COCO
(object) segmentation.
Following the convolutional and pooling layers we use
up to 3 fully connected layers, with the so-called Rectified
Linear Units (ReLU) neuron models, i.e., neurons with a
linear activation function, for positive input values, and a
zeroing function else-where. Other networks such as VGG-
16 (e.g. [23]) could also be used, but they have been mainly
designed for human face analysis applications.MRI andDaT
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Fig. 5 The CNN part of the CNN-RNN architecture feeds the RNN
part which yields the final outputs
Scans are provided at the input of these networks. When
epidemiological and clinical data values are to be considered,
they will be provided directly to the FC1 layer.
Figure 5 shows the CNN–RNN architecture. The CNN
part of the neural architecture, using a linear FC3 layer pro-
vides continuous clinical data estimation. The CNN feeds the
RNN part with the neuron outputs of its second FC layer (F).
The RNN accepts F1,F2,F3. . .,FN and delivers predicted
values O(1), …, O(N) through time, at its output. A total
of 4 images are given to the architecture as a single input.
These include 3 greyscale consecutive frames from an axial
T1 MRI and a colour DaT scan.
To implement this architecture, we first perform transfer
learning of theweights of the convolutional and pooling parts
of, e.g., the ResNet network to it. These parts are then fixed
during the training phase, where we only train the fully con-
nected layers of the system. The pre-trained convolutional
networks have already learnt to generate rich image repre-
sentations that have proven adequate for image classification
and segmentation. These representations are abstract enough
to help with specialized tasks, such as the analysis of MRIs
and DaT Scans.
This leaves the fully connected part of the network, which
is the only part of the network that we actually train in
the CNN case. Many variants of this approach have been
designed and tested. We selected to freeze the weights of
some of the fully connected layers, particularly those belong-
ing to the first FC layer. We have also considered some
additional weights of the network as free parameters, by
applying fine tuning (a smaller learning rate value) to the
weights of (some of) the convolutional layers of the ResNet
network, while using a normal learning rate value for the FC
part of it.
We use the TensorFlow Platform as the main tool for
generating the software implementation of the presented
architecture. TensorFlow is a toolkit which got published by
Google, under Apache License 2.0. It is mainly implemented
using C++, with a significant bit of Python. Its architecture
provides the ability to deploy computation to one or more
CPUs or GPUs in a desktop, server, or mobile device with a
single API.
A novel method for deep neural network
adaptation and transparency
We aim at providing the deep neural architecture with the
ability to adapt to new subject cases, assisting doctors with
efficient patient-specific analysis and treatment selection,
without forgetting its former knowledge. Our methodol-
ogy is based on a new network retraining approach which
extends the work in [5,19]. This approach uses clustering
[26] of trained system internal representations, in particular,
of the neurons’ outputs at the last fully connected CNN layer
(denoted, in vector form, as F in Fig. 5), or at the last hidden
RNN layer (let us denote them, in vector form, as u, and con-
sider them feeding the output units o). We use the centres of
these clusters as knowledge extracted from the data-driven
supervised training of the DNN architecture.
Whenever a new subject’s data are applied to the input
of the DNN end-to-end architecture, the latter computes the
respective internal representations and provides a prediction
at its output. Our approach is next to compute the distances of
these representations from the above described cluster cen-
tres and use them to validate, or not, the DNN prediction on
these new data. If one of these distances is small, compared
to some appropriate threshold, then classification of the new
data is made in the same category (patient/non-patient) with
that of the specific cluster, generally coincidingwith theDNN
prediction. If all distances are large, then a drift in the DNN
modelling procedure is detected. In the case of drift, we need
to train again the DNN including the new data. However, we
do not perform the usual fine-tuning procedure. We choose
to retrain the fully connected CNN layers and/or the RNN
hidden and output layers, using, on the one hand, the input
(image) data corresponding to the cluster centres (Existing
Knowledge) and, on the other hand, the new data.
Following this retraining procedure, we avoid the catas-
trophic forgetting problem in DNN systems, which occurs
when we apply repeated fine-tuning to new data cases. This
is so, because we keep both the old knowledge (through
the cluster centres’ information) and the new information
provided by specific subject cases. Following retraining, we
update the cluster centres as well, after medical validation of
the new data, so as to create personalised system knowledge
instances.
In particular, the retraining procedure can be implemented
as follows:
Let us first consider that, based on the training of the deep
neural architecture for Parkinson’s, a specific set, say Sb,
including the training input data corresponding to the previ-
ously computed cluster centres and the respective annotations
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(patient/non-patient), has been created. Let y(i) denote the
network output when applied to a new data sample, i =
1, 2, . . ., not included in the previous network training data
set.
Let wb include all already computed weights of the fully
connected and output layers in a CNN network—and of hid-
den layers in a CNN–RNN network—before retraining and
wa the new (updated) weight vector which will be obtained
through retraining. In particular, let wlb and w
l
a , respectively,
denote the weights connecting the outputs of the last hidden
layer, say u, to the network outputs, y.
A training set St is assumed to include the new input
(image) data; this will normally include a rather small num-
ber of data.
In the proposed retraining procedure, the new network
weights,wa , are computed byminimizing the following error
criterion:
Ea = Et,a + η · E f,a (1)
where Et,a denotes the error performed over training set
St , i.e., over current input information and E f,a is the cor-
responding error performed over training set Sb, i.e., over
previous deep neural network knowledge. Parameter η is a
weighting factor accounting for the significance of the cur-
rent training set compared to the former one. In our approach,
we minimize (1) by assuming that a small perturbation of the
weights of the fully connected (and/or hidden) layers in the
CNN (or CNN–RNN) network is enough to achieve good
classification performance in the current conditions. Conse-
quently, we get:
wa = wb + w (2)
and, similarly,
wla = wlb + wl (3)
with w and wl being small weight increments. This
assumption permits linearization of the nonlinear activation
neuron function, using a first-order Taylor series expansion.
It is possible to use theMean Square Error (MSE) criterion
for both quantities in the right-hand side of (1). In this case,
we use normal deep learning for CNN and/or RNN networks
[12], implemented in the TensorFlow environment. It can
be also possible to stress the importance of current data in
the minimization of (1). In this case, we replace the first
term in the right-hand side of it by the constraint that the
actual network outputs za(i), after retraining, are equal to
the desired ones, i.e.,
za(i) = d(i), for all data i in St (4)
Let us denote the difference of the actual network outputs,
after and before retraining, in the case of a CNN network, as
follows:
z(i) = za(i) − zb(i) (5)
Through linearization and using the fact that the outputs z
are weighted averages of the last hidden layer’s outputs u,
with the wl weights, it can be shown that
za(i) = zb(i) + f ′b · wlb · ul(i) + wl · ulb(i) (6)
where f ′ accounts for the derivative of the activation function
of the network output neuron(s).
Using Eq. (4) in (6) we get
d(i) − zb(i) = f ′b · wlb · ul(i) + wl · ulb(i) (7)
All quantities in Eq. (7) are based on former network values,
apart from the updates of the weightswl and of the outputs
ul . Thus Eq. (7) relates the targeted weights updates in the
network output with the outputs of the last hidden layer.
By continuing linearization of the difference of the u val-
ues, towards the previous fully connected layers, we replace
the ul(i) term with its equivalent in terms of the weights
of the former layers. This continues until we reach the last
convolutional layer, which we use with no retraining, and
therefore u is zero.
In this way, similarly to [5] we compute the weight incre-
ments w by solving a set of linear equations, over all data
in St :
c = A · w (8)
with matrix A being computed in terms of previously trained
weights, aswas above described,while the elements of vector
c are defined as follows:
c(i) = d(i) − zb(i), for all data i in St (9)
and zb(i) denotes the outputs of the originally trained net-
work, when this is applied to the data in St .
The size of vector c is smaller than the number of unknown
weights w, thus many solutions exist for (8). Uniqueness,
however, is imposed by an additional requirement which is to
select the solution that causes a minimal degradation of the
previous network knowledge. This is of great significance in
our approach, since this knowledge (and the respective clus-
ter centres) has been, normally, already validated by medical
experts and, therefore, should be changed the least possible.
Thus, the retraining problem results in minimization of
(1) subject to constraints (3) and the constraint for small
weight increments. A variety of methods can be used for this
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Fig. 6 MRI scan of a patient without Parkinson’s Disease. Axial orientation—T1 sequence
Fig. 7 MRI scan of a patient with Parkinson’s Disease. Axial orientation—T1 sequence
minimization. One of them is the gradient projectionmethod,
which, starting from a feasible point, moves in a direction
which decreases the error criterion and satisfies the above
constraints. This is used for CNN network retraining in the
TensorFlow environment. Extension in the CNN–RNN case
is more complex, also taking into account the time evolution
and derivatives of the u values.
In addition to personalized diagnosis and prediction, the
proposed approach allows the deep neural architecture to
exhibit transparency in its decision making. In particular, for
each cluster centre, the respective medical input and desired
output data are stored in the database, as representative of
all data belonging to this cluster. Whenever, upon presen-
tation of new input data to the DNN, the obtained output
vector matches that of a specific cluster centre, then the
respective input image and medical data are presented to the
clinician/user to illustrate that this similarity has been taken
into account by the network in computing its prediction.
Experimental study
The current size of the generated fully annotated database is
78 subjects (over a half of the size to be finally generated),
with a ratio of 2:1 between Parkinson’s patients and non-
Parkinson’s patients.At this stage, it consists ofMRI andDaT
scans, annotated as belonging to subjects with Parkinson’s or
not.
Dataset generation
We generated a dataset of about 100.000 combinations of
color DaT scans with triplets of consecutive MRI gray scale
images, covering both patient and non-patient categories.
Each input (combination) consists of three MRI images and
one RBG DaT scan image. To obtain a balanced dataset,
we applied various augmentation techniques, such as over-
sampling the latter category, or under-sampling the former
[1]. The above were then used as data for designing the end-
to-end deep neural architectures.
Fig. 8 DaT scan from a patient without Parkinson’s Disease (left).
Respective image from a patient with Parkinson’s (right)
We used about 70%of this data for training the deep neural
architectures. Moreover, we kept the original data (corre-
sponding to the rest 30% of augmented data) of 15 subjects
(out of the current 78 in our database) for validation and test-
ing. It should be emphasized that our target has been to test
the ability of the networks to learn from a number of patients
and generalize their performance to other subjects, who have
not been included in the training set. For this reason, the
test data consisted of six new subjects, four with Parkinson’s
(PD patients) and two without (Non-PD patients, denoted
NPD), to provide about 1.200 test input samples. The net-
works had two linear outputs, with targeted values (1,0) and
(0,1), respectively, for the two categories.
As a reference, 10 consecutive frames from an axial T1
brainMRI are presented in Fig. 6 for a patientwithout Parkin-
son’s, and 10 more in Fig. 7 for a patient with the disease.
Figure 8 shows twoDaT scans of patientswithout andwith
Parkinson’s Disease, respectively. The dopamine deficiency
can be seen in these images.
Network training
As a first approach, we selected to train the CNN and
CNN–RNNdeep neural networks from scratch; starting from
random initial weights in the convolutional and fully con-
nected (FC) parts of the CNNs, or the convolutional and
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in each FC Layer
Accuracy
1 1 1000 0.57
2 1 2622 0.60
3 2 2622–500 0.90
4 2 2622–1000 0.91
5 2 2622–1500 0.94
6 2 2622–2000 0.93
hidden layers of the CNN–RNNs. As a second approach,
we adopted transfer learning, i.e., transfer of the weights of
the convolutional and pooling layers of a pretrained CNN,
to the generated networks. Then, the ‘upper’ FC part of the
targeted CNN network, as well as the RNN hidden layers of
the CNN–RNN, were designed and trained with the above
dataset. For the initialization of these weights, we used the
ResNet-50 CNN, which has been pre-trained with millions
of general type RGB images for this purpose. A separate
system was used for each of the image types in our inputs,
i.e., one focusing on the MRI triplets and another focusing
on the DaT scan. We concatenated the outputs of these two
ResNet substructures at the input of the first FC layer of the
CNN network. It is at this layer, that epidemiological data
will be concatenated as well, when the whole database will
have been generated.
Based on this procedure, we separately trained both a deep
CNN network and a deep CNN–RNN network for Parkin-
son’s disease diagnosis.
Experimental evaluation
Table 1 summarizes the results obtained through different
configurations of the CNN network, i.e., ones with different
numbers of hidden layers and hidden units per layer.An accu-
racy of 96% on training data set was obtained (with network
weights selected based on the performance on the validation
data set); an accuracy of 94% on testing dataset was obtained
in this experiment, as shown in Table 1, which is very satis-
factory.
Table 2 summarizes the accuracy obtained by the CNN–
RNN (with GRU neuron model) architecture, for different
respective structures, with weights selected similarly, based
on performance on the validation data set). The addition of
theRNNpart allows the deep neural architecture to better fol-
low time varying correlations in theMRI sequence of triplets
of frames, thus increasing the accuracy of Parkinson’s pre-
diction to 98% on the testing data set.
There are some additional metrics obtained in terms of the
above results. In the best reported case (line 3 of Table 2),
Table 2 Performance on test data of the trained end-to-end CNN–RNN
architecture for Parkinson’s
CNN–RNN architectures: Number of units
in the FC layer
Accuracy
1 Fully connected layer
2 Hidden layers (128 units each)





Fig. 9 CNN Performance on validation data, during training epochs
Fig. 10 CNN–RNN Performance on validation data, during training
epochs
the MSE value was very low, equal to 0.02. Considering the
binary problem examined in this paper (PD/NPD), precision
attained was 1.00 and recall was 0.96 (F1 value was 0.98).
Figures 9 and10 show the accuracyobtainedby the end-to-
end deep CNN and CNN–RNN architectures, respectively,
on the validation/test data set, during training. It can be shown
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that the best accuracy of the CNN architecture is obtained
early in the learning phase, afterwards reaching overfitting
conditions. It can also be observed that the Deep CNN–RNN
architecture takes longer to derive the best performance than
the CNN one.
It should be mentioned that the best performance of the
CNN–RNN architecture was 99,97% on the training data
and 98% on the test data. The test data set consisted of about
1200 input data (original, i.e., not augmented, MRI triplets
andDaTScans) from six subjects; none of their data had been
included in the training data set. About 600 data concerned
each one of the PD and NPD categories. The performance on
test data was 96% for PD and perfect, i.e., 100%, for NPD
patients. In particular, Table 3 shows the percentage of correct
classifications for each test subject’s data (combinations of
MRIs and DaT scans).
This is an excellent result, which shows the potential of
the deep CNN–RNN architecture to provide very accurate
predictions of Parkinson’s disease.
We then applied the proposed clustering procedure on the
representations (vector of neurons’ outputs) generated at the
last hidden layer of the trained CNN and CNN–RNN archi-
tectures. The best results were obtained with 5 clusters, 3
corresponding to the Parkinson’s Disease (PD) cases and 2
to the Non-Parkinson’s (NPD) case, as described in the next
Section.
Clustering visualization
In order to visually illustrate the distribution of data in cate-
gories, Principal Component Analysis (PCA) was performed
on the representations obtained through processing of the test
data. Focus was put on the derived two main principal com-
ponents, as shown in Figs. 11a and 12a, for the CNN and
CNN–RNN architectures, respectively.
Figure 11a shows the distribution of the representations
obtained for PD and NPD subjects, as derived from the CNN
architecture. It should be mentioned that the last CNN fully
connected layer consisted of 1500 neurons. However, due to
the ReLU activation function, only about 30 neurons yielded
Fig. 11 a The two main principal components of the CNN representa-
tion. bVisualization of (three) cluster boundaries for the NPD category
provided by an OCSVM approach. cHistogram of the derived OCSVM
outputs
non-zero values in this representation. Figure 11b verifies
the ability of a one-class support vector machine (OCSVM)
[26], to determine clusters corresponding to the NPD class,
as shown in Fig. 11b.
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Fig. 12 a The two main principal components of the CNN–RNN rep-
resentation. b Visualization of (one) cluster boundary for the NPD
category provided by an OCSVM approach. cHistogram of the derived
OCSVM outputs
It is interesting to mention the variability of the PD cases
compared to the NPD ones. This is in accordance with the
lower accuracy obtained by the DNN architecture in the PD
Table 4 Cluster precision on the training set
Cluster category 1 2 3 4 5
PD 0 5 18277 1516 18163
NPD 2822 25393 0 0 0
Fig. 13 Projection in 3-D of cluster centres’ representations
class, when compared to the NPD case. Figure 11c shows a
histogram of the OCSVM values also illustrating this obser-
vation.
The respective results obtained for the representations pro-
vided by the CNN–RNN architecture are shown in Fig. 12a–
c. It should be mentioned that, in this case, the obtained
representations consisted of 128 neuron output values, com-
puted through the tanh activation function. However, only
about 20 of the neurons provided significant non-zero values;
the rest yielded very small, practically negligible, values.
By comparing these results with the respective ones in
Fig. 11a–c, it is concluded that theCNN–RNNarchitecture—
which has achieved a better performance than CNN—has
been able to produce much more compact representations
for each category, with well separated clusters.
There were five clusters generated by the proposed
approach, three for the PD category and 2 for the NPD one.
An indication of the purity (precision) of the clusters in the
augmented training data set can be viewed in Table 4. Four
clusters have a precision equal to 1.00, with one having a
0.9998 precision.
We computed the cluster centres, as the mean values of
all 128-dimensional vector representations included in each
cluster. Their projection in 3-D is shown in Fig. 13, show-
ing the significant distance values between them. Moreover,
Table 5 shows the corresponding maximum mean squared
distance of the representations in each cluster from the cor-
responding cluster centre.
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Table 5 Maximum intra-cluster distance
Cluster 1 2 3 4 5
Distance (MSE) 0.01 0.02 1.565 0.158 0.14
Figure 14a–e illustrate the input images corresponding to
the 5 cluster centres that were derived from the CNN–RNN
architecture. The clusters have been sorted by the level of
degeneration of the basal ganglia (lentiform nucleus, caudate
nucleus). The 5 cluster centres roughly represent the 3 stages
of DaT loss in PD, as confirmed by medical experts. This
provides transparency and is the basis for interpretability of
the decision making process implemented and achieved by
the proposed deep neural architecture.
Let us now proceed with analysis of new subject data
which have not been included in the developed system design
phase. Let us consider the test data described in Table 3 for
this purpose. Since the six subject cases span different pos-
sible scenarios, we will evaluate them in two different steps.
Let us first consider, the 4, 17 and 21 subjects of Table 3
(one from the PD category and two of the NPD category),
all data of whom are correctly predicted (100% accuracy)
by the CNN–RNN architecture. The internal representations
(128-dimensional vectors) generated at the output of the sec-
ond hidden layer of the RNN were also correctly classified,
based on their distances from the centres of the clusters
derived from the trained CNN–RNN respective internal rep-
resentations. All classifications provided by the trained DNN
architecture for the data of these three subjects have been,
therefore, accepted by our derived end-to-end contextualiza-
tion approach and formed the finally obtained predictions.
Since the training database has now been increased with
three new subject datasets, we can perform an updating of
the centres of the clusters to which the new data have been
included. Let us assume that a single vectorm[ j], j = 1, 128,
is used to update the centre ci of the i-th cluster composed
of Ni members. Then, the new class centre ci,new will be
slightly modified, as follows:
ci,new[ j] = Ni · ci,old[ j]/(N + 1) (10)
Consequently, an updated, slightly different, systemmemory
is produced, incorporating the new knowledge about the new
subjects’ data.
Let us now focus on the three remaining cases of Table 3,
all referring to PD patients. 10 input combinations, out of
120, 3 out of 204 and 8 out of 184 input combinations, respec-
tively, have been erroneously classified, as NPD cases, both
by the CNN–RNN architecture and the cluster-based repre-
sentation. It should, however, be stressed that in all these
cases the distances of the computed representations from the
5 cluster centres have been larger than the respective max-
imum intra-cluster distances presented in Table 5. This has
been the criterion for considering these cases, as new ones,
which require insertion of new cluster centres and retraining
of the DNN network with them.
We should mention that, these cases constitute only a 9%,
1.5 and 4.5 of the data obtained by each of these patients,
respectively. Thus, we assume that clinician only examines
them and provides his/her own diagnosis. Following this val-
idation, two new clusters have been added to the PD existing
ones, one of which has been close, but distinct, to the 1st
NPD cluster centre and the other close, but distinct, to the
2nd NPD cluster centre.
In addition,weused the adaptationmethodologydescribed
in Section “A novel method for deep neural network adap-
tation and transparency” to successfully retrain the DNN
architecture so as to accurately classify the new data as well,
while keeping the formerly achieved performance. The new
dataset in Eqs. (1) and (4) consisted of the above described
21 input data samples. The performance obtained by the
network, after weight adaptation, was similar to the one
obtained, when retraining the network with all available data
in the database.
In all the above experiments, for DNN training, we used
the Adam optimizer algorithm, in mini batches, considering
the Mean Squared Error (MSE) as cost function.
Hyper-parameter value selection
For the CNN architecture, the hyper-parameter values were
selected as follows: a batch size of 30 (15 examples from
each category), a constant learning rate of 0.001; 2622 and
1500 hidden units, respectively, in each fully connected layer
and dropout after each fully connected layer with a value of
0.5. We also used biases in the fully connected layers.
For the CNN–RNN architectures the hyper-parameters
were selected to match the previous ones, apart from the
batch size which was 40 (20 examples from each category)
and the number of hidden units in the GRU layers, both of
which were 128.
The weights of the fully connected layers were initialized
from a Truncated Normal distribution with a zero mean and
a variance equal to 0.1 and the biases were initialized to 1.
Training was performed on a single GeForce GTXTITAN
X GPU and the training time was about 2–3days.
Conclusions and further work
We have designed novel end-to-end deep neural architec-
tures, composed of CNN and RNN components, appropri-
ately trained with medical imaging data, and have obtained
very good performances in diagnosis and prediction of
Parkinson’s disease. We have been developing and publi-
cizing a new database, which we have used for training and
123
130 Complex Intell. Syst. (2018) 4:119–131
Fig. 14 a The first cluster
centre corresponds to a typical
frame from a DaT scan of an
individual not suffering from
PD. b The second cluster centre
represents an interesting case of
an image that seems to be
pathological but belongs to a
healthy individual. Though the
lentiform Nucleus appears to be
completely gone, there is no
diffusion of the contrast agent in
the brain. The latter could be
viewed as an indication that the
main structures are, in fact,
intact. c The third cluster
represents the early stages (1–2)
of the degeneration associated
with PD, as both lentiform
nuclei appear to be diminishing.
d The fourth cluster is a typical
stage 2 DaT loss. Both lentiform
nuclei are completely gone; the
only signal is from the caudate,
which appear as two almost
symmetrical circular areas. e
The fifth cluster is the most
advanced stage of DaT loss,
stage 3. Here the basal ganglia
appear further degenerated,
while there is significant activity
in the rest of the brain. This is an
indication that these structures
have lost their ability to contain
the contrast agent and it has
diffused throughout the brain
evaluating the performance of the new deep neural architec-
tures.
Moreover, we have proposed a novel unsupervised app-
roach, based on clustering of the trained DNN internal
representations, which provides the deep neural architecture
with the ability to adapt to new data cases, without suffer-
ing the catastrophic forgetting problem, usually met in DNN
fine-tuning adaptation methodologies. This procedure also
provides a type of transparency in the decision making pro-
cess implemented by the deep neural architecture.
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In our current research, with the aid ofmedical experts, we
correlate the generated clusters with the medical and clinical
data and try to create descriptions relating theDNNdecisions
with the developed cluster characteristics, as well as using
more detailed grading schemes in the data annotation and
more categories in the classification task. This is the basis for
providing explanations of the network’s performance, thus,
rendering its use transparent and trustful, while providing
more detailed predictions about Parkinson’s disease evolu-
tion.
A lot of research has been made on neuro-symbolic
learning and reasoning, i.e., merging neural networks with
knowledge representation, also involving deep neural net-
works [7,20] and on extracting rules from trained networks
[15]. We will also investigate the use of these methods to
provide formal representations of the generated Parkinson’s
knowledge and/or extract additional rules that may further
justify the predictions and assessments of the designed deep
neural architectures.
Our future research aims at extending the developments
obtained for the Parkinson’s case to other degenerative dis-
eases, which are based on similar input medical imaging
information.Wefirst target dementias andAlzheimer’s, using
a recently presented database in [6]. Following the approach
proposed in the paper, we will use transfer learning to retrain
the DNNs designed for Parkinson’s on datasets describing
other diseases.
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